CCS
ZLTQ

Crosspoint Capital Strategies’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Crosspoint Capital Strategies’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-145
Closed -$4K – 667
2015
Q1 		$4K Buy
+145
New +$4.64K ﹤0.01% 482

Other funds holding ZLTQ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Crosspoint Capital Strategies's ZLTQ Position: Q2 2015 in Review

Crosspoint Capital Strategies sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2015, closing a stake of 145 shares — an estimated $4K sold.

Crosspoint Capital Strategies first reported a position in ZLTQ in Q1 2015 and held it in 1 quarter. The position peaked at $4K in Q1 2015. 152 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2015.

  • Crosspoint Capital Strategies reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 145 ZELTIQ Aesthetics, Inc. shares in Q2 2015, an estimated $4K.
  • Crosspoint Capital Strategies first reported a position in ZELTIQ Aesthetics, Inc. in Q1 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's ZELTIQ Aesthetics, Inc. position peaked at $4K in Q1 2015.
  • 152 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2015, filed 24 Aug 2015.